David A. Garrison - Jun 2, 2025 Form 4 Insider Report for HARTE HANKS INC (HHS)

Role
Chief Financial Officer
Signature
/s/ Robert Wyman, Attorney-in-fact for David A Garrison
Stock symbol
HHS
Transactions as of
Jun 2, 2025
Transactions value $
$113,750
Form type
4
Date filed
7/3/2025, 01:09 PM
Previous filing
Nov 25, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GARRISON DAVID A Chief Financial Officer 1 EXECUTIVE DRIVE SUITE 303, CHELMSFORD /s/ Robert Wyman, Attorney-in-fact for David A Garrison 2025-07-03 0001259993

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HHS Common Stock Award $114K +25K $4.55 25K Jun 2, 2025 Held by Harte Hanks until vested F1
holding HHS Common Stock 13.1K Jun 2, 2025 Shares held in participant's retirement account. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HHS Option to buy Common Shares 64.6K Jun 2, 2025 Common Stock 64.6K $7.74 NQ stock options granted and held by Harte Hanks, Inc. until exercised. F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Participant was granted 25,000 RSU shares on 6/02/2025 (contract signed on 7/03/25) which will vest in three equal tranches on the anniversary of the grant date over the following three consecutive years.
F2 Shares were purchased and held in participant's retirement account.
F3 1/3 of options vests annually on January 29, beginning in 2025 and ending in 2027.
F4 Participant was granted 64,600 NQ stock options on 1/29/2024 that will vest 33% on the first three anniversaries of the grant date, 1/29/2025, 1/29/2026, and 1/29/2027.